Invention Grant
- Patent Title: Bis-heterocyclic imidazolyl compounds
- Patent Title (中): 双杂环咪唑基化合物
-
Application No.: US12900779Application Date: 2010-10-08
-
Publication No.: US08263615B2Publication Date: 2012-09-11
- Inventor: Peter Herold , Robert Mah , Vincenzo Tschinke , Michael Quirmbach , Christiane Marti , Aleksandar Stojanovic , Stefan Stutz
- Applicant: Peter Herold , Robert Mah , Vincenzo Tschinke , Michael Quirmbach , Christiane Marti , Aleksandar Stojanovic , Stefan Stutz
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Wenderoth Lind & Ponack, L.L.P.
- Priority: EP05111907 20051209
- Main IPC: A61K31/437
- IPC: A61K31/437 ; C07D487/04 ; C07D471/04 ; A61K31/4188 ; A61P9/12 ; A61P3/06 ; A61P3/00 ; A61P9/04

Abstract:
Heterocyclic compounds of the general formula (I) are provided in which R, R1, R2, R3, R4 and n have the definitions elucidated in more detail in the description, to a process for preparing them and to the use of these compounds as medicaments, particularly as aldostereone synthase inhibitors,
Public/Granted literature
- US20110028512A1 BIS-HETEROCYCLIC IMIDAZOLYL COMPOUNDS Public/Granted day:2011-02-03
Information query
IPC分类: